文献速递产科母胎医学

分娩时SARS-CoV-2抗体在产妇、伴侣及新生儿中的研究

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies at Delivery in Women, Partners, and Newborns.
PubMed 文献 · Obstet Gynecol · 2021-01-01

研究在丹麦一家大学医院从2020年4月4日至7月3日邀请所有分娩产妇及其伴侣和新生儿参与,检测咽拭子SARS-CoV-2 RNA和血样抗体。未发现SARS-CoV-2抗体与产科或新生儿并发症相关,但统计功效低。

要点

  • 产妇调整后SARS-CoV-2抗体血清阳性率为2.6%,伴侣为3.5%。
  • 未发现抗体与早产、子痫前期、剖宫产等并发症相关,但统计功效低。

核心结论

  • 未发现SARS-CoV-2感染与产科或新生儿并发症相关。
  • 伴侣有抗体时产妇感染绝对风险为39%。

研究设计与样本

  • 2020年4月4日至7月3日在丹麦一家大学医院进行的前瞻性研究。
  • 共1313名产妇(占同期分娩产妇72.5%)、1188名伴侣和1206名新生儿参与。
  • 产妇和伴侣入院时采集咽拭子和血样,分娩后立即采集脐带血。
  • 咽拭子用PCR检测SARS-CoV-2 RNA,血样检测SARS-CoV-2抗体。

主要发现

  • 调整后血清抗体阳性率产妇为2.6%,伴侣为3.5%。
  • 未发现SARS-CoV-2抗体与早产、子痫前期、剖宫产、Apgar评分、低出生体重、脐动脉pH、需持续气道正压或新生儿入院等并发症相关。
  • 1051个完整血清学数据家庭中,伴侣有抗体时产妇感染绝对风险为39%。

临床怎么用

  • 临床可参考:伴侣有SARS-CoV-2抗体时产妇感染风险较高(绝对风险39%)。
  • 因统计功效低,不能排除小型但可能有意义的差异,需谨慎解读阴性结果。

局限性

  • 研究缺乏统计功效检测有和无感染证据者之间小型但可能有意义的差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the frequency of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in parturient women, their partners, and their newborns and the association of such antibodies with obstetric and neonatal outcomes. METHODS: From April 4 to July 3, 2020, in a single university hospital in Denmark, all parturient women and their partners were invited to participate in the study, along with their newborns. Participating women and partners had a pharyngeal swab and a blood sample taken at admission; immediately after delivery, a blood sample was drawn from the umbilical cord. The swabs were analyzed for SARS-CoV-2 RNA by polymerase chain reaction, and the blood samples were analyzed for SARS-CoV-2 antibodies. Full medical history and obstetric and neonatal information were available. RESULTS: A total of 1,313 parturient women (72.5.% of all women admitted for delivery at the hospital in the study period), 1,188 partners, and 1,206 newborns participated in the study. The adjusted serologic prevalence was 2.6% in women and 3.5% in partners. Seventeen newborns had SARS-CoV-2 immunoglobulin G (IgG) antibodies, and none had immunoglobulin M antibodies. No associations between SARS-CoV-2 antibodies and obstetric or neonatal complications were found (eg, preterm birth, preeclampsia, cesarean delivery, Apgar score, low birth weight, umbilical arterial pH, need for continuous positive airway pressure, or neonatal admission), but statistical power to detect such differences was low. Full serologic data from 1,051 families showed an absolute risk of maternal infection of 39% if the partner had antibodies. CONCLUSION: We found no association between SARS-CoV-2 infection and obstetric or neonatal complications. Sixty-seven percent of newborns delivered by mothers with antibodies had SARS-CoV-2 IgG antibodies. A limitation of our study is that we lacked statistical power to detect small but potentially meaningful differences between those with and without evidence of infection.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Egerup P, Fich Olsen L, Christiansen AH, et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies at Delivery in Women, Partners, and Newborns. Obstet Gynecol. 2021. PMID: 33116054. doi:10.1097/AOG.0000000000004199

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。